Belgium-headquartered biotech company Promethera Biosciences has announced the closing of a €39.7 million ($44 million) Series D financing round co-led by new Japanese investors ITOCHU Corporation and Shinsei Capital Partners.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
